Executive Director, Worldwide Cell Therapy Medical Communications Lead

Key Responsibilities

• Lead CT Medical scientific disclosure strategy for the Cell Therapy portfolio across asset lifecycles, including manuscripts, abstracts, posters, oral presentations, and selected reactive materials.
• Represent CT Medical as the primary Medical Communications partner to Global Development, Clinical Operations, Translational Medicine, Commercial, Market Access, Patient Safety, Regulatory, Quality, and Manufacturing/Supply—ensuring integrated, patient-centered scientific communications that reflect the realities of cell therapy development and delivery.
• Ensure external communications align with development strategy, evidence generation plans, asset maturity, and enterprise priorities while meeting ethical and compliance standards.
• Serve as accountable owner of reputational, journal, investigator, and compliance risk related to scientific communications, including escalation and decision support for complex/novel scenarios.
• Serve as CT Medical lead for publication governance and policy interpretation; establish clear CT Medical decision rights, operating cadence, and cross-functional expectations to enable speed with rigor.
• Drive adoption of best practices, tools, and operating models to improve Medical Communications effectiveness and efficiency, including standardized workflows across indications and assets.
• Establish CT Medical standards for scientific publications, scientific content, and independent medical education in alignment with applicable SOPs and external codes (e.g., GPP) across the Cell Therapy portfolio.
• Build and sustain Medical Communications leadership capability through talent development and succession planning; coach teams to operate effectively in a complex, matrixed, global environment.
• Cultivate a culture of collaboration, inclusion, and continuous improvement.

Qualifications & Experience

• Knowledge of Good Publication Practice (GPP), Sunshine Act, and post-marketing scientific communications guidance.
• Deep expertise in external scientific communications across the asset lifecycle, including complex modalities (cell therapy/advanced therapies strongly preferred).
• Understanding of the cell therapy ecosystem and end-to-end value chain (e.g., clinical development, treatment centers, manufacturing/quality interfaces), and the implications for scientific disclosure and stakeholder engagement.
• Executive-level scientific and strategic communication skills.
• Ability to influence in complex, global, matrixed environments.
• Experience managing global teams and operating in enterprise settings.
• Leadership Attributes: Enterprise mindset, change leadership orientation, high learning agility. Inclusive, collaborative leadership style aligned with BMS values.